Latest News
- Min. Nadda Unveils ?13,000-Crore Bio-Pharma SHAKTI and Chemical Parks Push to Expand India’s Global Chemicals and Biologics Footprint
- Aurobindo Pharma Subsidiary Launches Generic Cancer Drug in US, Expands Oncology Portfolio in Global Generics Market
- KIMS Hospitals Introduces Adaptive Deep Brain Stimulation in India for Advanced Parkinson’s Treatment
Digital healthcare can be an effective preventive tool against diseases: Jitendra Singh
- By Newsdesk
- New Delhi
- Aug 24, 2023
Jitendra Singh, the Minister of State (Independent Charge) for Science and Technology, emphasized the potential of digital healthcare as a preventive measure against a variety of diseases, ranging from lifestyle conditions like Type 2 diabetes to infectious ailments like Covid. He made these remarks during the 3rd Healthcare Leaders' Summit in New Delhi, where he discussed India's digital healthcare strategy for ensuring accessible and affordable healthcare.
Singh underscored the upcoming focus on digital healthcare with a preventive approach. He stressed the urgency of a public-private partnership (PPP) model in healthcare, particularly to eliminate the healthcare disparities between urban and rural areas. He believes that leveraging science and technology can bridge these gaps by emphasizing affordability, inclusivity, and accessibility.
The minister noted India's advancements in enhancing its healthcare infrastructure over time. He highlighted the shift in disease patterns, including the emergence of lifestyle and coronary diseases, along with increased life expectancy, post the 1980s.
Singh acknowledged the role of science and technology in addressing societal needs and global challenges. He discussed the Anusandhan National Research Foundation (ANRF) Bill, designed to encourage research and development investments. He detailed the proposed PPP entity, with substantial research funding from the private sector (₹36,000 crore) and the government's contribution (₹14,000 crore) to foster greater industry involvement.
The minister recognized India's prominent position in diabetes research globally and prioritized diabetes prevention in youth and pregnant women. He emphasized the significance of preventive healthcare and mass screening, especially given India's youthful population, to align with Prime Minister Modi's growth targets for the economy by 2047.